| Dr Maria Rizkallah Boustani, MD | |
|
421 Carriage Dr, Beckley, WV 25801-2805 | |
| (304) 256-0242 | |
| (304) 256-0244 |
| Full Name | Dr Maria Rizkallah Boustani |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 36 Years |
| Location | 421 Carriage Dr, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518917632 | NPI | - | NPPES |
| 001711048 | Other | WV | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 18402 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Raleigh General Hospital | Beckley, WV | Hospital |
| Beckley Arh Hospital | Beckley, WV | Hospital |
| Princeton Community Hospital | Princeton, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rheumatology And Pulmonary Clinic Pllc | 0446340822 | 2 |
News Archive
Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with its presentation at the American Thoracic Society international conference.
Despite the positive results of small studies and a widely held belief in its benefit, the practice of keeping female patients immobilised after intrauterine insemination has no beneficial effect on pregnancy rates, according to results of a large randomised study presented here at the Annual Meeting of ESHRE in Helsinki.
WESTCHESTER, Ill. - In the first known study of its kind, an article published in the August 1st issue of the journal SLEEP finds that children with attention deficit hyperactivity disorder (ADHD), and whose sleep efficiency is poor, experience significant improvement on some measures of the Continuous Performance Test (CPT) if they are treated with methylphenidate (MPH).
A non-toxic and environmentally friendly way to make tiny nanorods of zinc oxide has been developed for the first time by researchers in Saudi Arabia. The approach, described in the current issue of the International Journal of Nanoparticles, could allow the nanorods to be used safely in medical and for other applications.
Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder.
› Verified 3 days ago
| Entity Name | Rheumatology And Pulmonary Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467439463 PECOS PAC ID: 0446340822 Enrollment ID: O20071221000492 |
News Archive
Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with its presentation at the American Thoracic Society international conference.
Despite the positive results of small studies and a widely held belief in its benefit, the practice of keeping female patients immobilised after intrauterine insemination has no beneficial effect on pregnancy rates, according to results of a large randomised study presented here at the Annual Meeting of ESHRE in Helsinki.
WESTCHESTER, Ill. - In the first known study of its kind, an article published in the August 1st issue of the journal SLEEP finds that children with attention deficit hyperactivity disorder (ADHD), and whose sleep efficiency is poor, experience significant improvement on some measures of the Continuous Performance Test (CPT) if they are treated with methylphenidate (MPH).
A non-toxic and environmentally friendly way to make tiny nanorods of zinc oxide has been developed for the first time by researchers in Saudi Arabia. The approach, described in the current issue of the International Journal of Nanoparticles, could allow the nanorods to be used safely in medical and for other applications.
Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maria Rizkallah Boustani, MD 421 Carriage Dr, Beckley, WV 25801-2805 Ph: (304) 256-0242 | Dr Maria Rizkallah Boustani, MD 421 Carriage Dr, Beckley, WV 25801-2805 Ph: (304) 256-0242 |
News Archive
Variation in the gene MUC5B among patients with idiopathic pulmonary fibrosis was associated with improved survival, according to a study published online by JAMA. The study is being released early online to coincide with its presentation at the American Thoracic Society international conference.
Despite the positive results of small studies and a widely held belief in its benefit, the practice of keeping female patients immobilised after intrauterine insemination has no beneficial effect on pregnancy rates, according to results of a large randomised study presented here at the Annual Meeting of ESHRE in Helsinki.
WESTCHESTER, Ill. - In the first known study of its kind, an article published in the August 1st issue of the journal SLEEP finds that children with attention deficit hyperactivity disorder (ADHD), and whose sleep efficiency is poor, experience significant improvement on some measures of the Continuous Performance Test (CPT) if they are treated with methylphenidate (MPH).
A non-toxic and environmentally friendly way to make tiny nanorods of zinc oxide has been developed for the first time by researchers in Saudi Arabia. The approach, described in the current issue of the International Journal of Nanoparticles, could allow the nanorods to be used safely in medical and for other applications.
Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder.
› Verified 3 days ago
Divya S. Rajan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1832 Harper Rd, Beckley, WV 25801 Phone: 681-207-7129 Fax: 681-207-7132 | |
Dr. Luis Alejandro Asencio Magdaleno, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1717 Harper Rd, Second Floor, Suite G, Beckley, WV 25801 Phone: 304-461-3922 | |
Dr. Seema Anand, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 | |
Thair A Barghouthi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 304 Carriage Dr, Beckley, WV 25801 Phone: 304-254-0892 Fax: 304-254-0893 | |
Dr. Hafiz Imran Iqbal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 242 George St, Beckley, WV 25801 Phone: 304-255-7878 Fax: 304-256-0060 | |
Norma J Mullins, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3771 Robert C Byrd Drive, Beckley, WV 25801 Phone: 304-255-5710 Fax: 304-255-5702 | |
Jose Jorge Gordinho, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2962 Robert C. Byrd Drive, Beckley, WV 25801 Phone: 304-254-9022 Fax: 304-254-9024 |